Deciphering the Structural and Functional Paradigms of Clostridioides difficile Toxins TcdA and TcdB
Расшифровка структурных и функциональных парадигм токсинов Clostridioides difficile TcdA и TcdB
2025-04-03
SCID: 54.1/htaxpz4t
Discuss with AI
Clostridioides difficile toxinsTcdA and TcdBcryo-electron microscopyglucosyltransferase toxinstoxin autoprocessing inhibitors
Figures from the paper
Abstract (AI)
Clostridioides difficile Infection (CDI) continues to be a major cause of antibiotic-associated diarrhea and pseudomembranous colitis, fueled in large measure by virulence factors TcdA and TcdB. These giant glucosyltransferase toxins interfere with host cytoskeletal integrity and inflammatory signaling by inhibiting Rho GTPase; however, the detailed structural dynamics, receptor selectivity, and subcellular trafficking mechanisms remain in part unspecified. This review integrates recent insights from cryo-electron microscopy (cryo-EM) and X-ray crystallography to describe the quaternary architecture of TcdA/B, emphasizing conformational changes key to pore formation and endosomal escape. We also examine the genomic heterogeneity of hypervirulent C. difficile strains (e.g., ribotype 027), correlating toxin gene polymorphisms (e.g., tcdC mutations) with increased toxin production and virulence. Mechanistic explanations of toxin-driven inflammasome activation and epithelial barrier dysfunction are situated within host immune evasion mechanisms, including microbiota-derived bile acid regulation of toxin stability. Subsequent innovative therapeutic strategies, encompassing the utilization of engineered neutralizing antibodies that specifically target the autoprocessing domain alongside structure-guided small-molecule inhibitors, are subjected to a rigorous evaluation. By integrating structural biology, systems-level omics, and clinical epidemiology, this review establishes a comprehensive framework for understanding C. difficile toxin pathogenesis and guiding next-generation precision antimicrobials.
Key Findings
1
Engineered antibodies targeting the autoprocessing domain and structure-guided small-molecule inhibitors represent promising precision therapeutic strategies against TcdA and TcdB.
2
Genomic heterogeneity in hypervirulent strains, including tcdC mutations in ribotype 027, is associated with increased toxin production and virulence.
3
Recent cryo-EM and X-ray crystallography studies clarify toxin quaternary architecture and conformational changes involved in pore formation and endosomal escape.
4
TcdA and TcdB disrupt host cytoskeletal integrity and inflammatory signaling by inhibiting Rho GTPases, driving major manifestations of C. difficile infection.
5
Toxin-induced inflammasome activation and epithelial barrier dysfunction contribute to pathogenesis, while microbiota-derived bile acids regulate toxin stability and host immune evasion.
Research Object
Clostridioides difficile toxins TcdA and TcdB
Research Subject
Their structural dynamics, receptor selectivity, subcellular trafficking, and mechanisms of host-cell damage, inflammation, and virulence
Publication Details
Publication Date
2025-04-03
Journal
Publisher
ISSN
Cited by
5
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest